paxilline has been researched along with sq-23377 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rowe, IC; Saleem, F; Shipston, MJ | 1 |
| Gibbs, TC; Knoepp, SM; Meier, KE; Park, JJ; Rubio, MV; Snider, AJ; Um, T; Xie, Y; Zhang, Z | 1 |
2 other study(ies) available for paxilline and sq-23377
| Article | Year |
|---|---|
Characterization of BK channel splice variants using membrane potential dyes.
Topics: Alternative Splicing; Calcium; Cell Line; Dose-Response Relationship, Drug; Exons; Fluorescent Dyes; Humans; Indoles; Ionomycin; Large-Conductance Calcium-Activated Potassium Channels; Membrane Potentials; Patch-Clamp Techniques; Potassium Channel Blockers; Transfection | 2009 |
Effects of lysophosphatidic acid on calpain-mediated proteolysis of focal adhesion kinase in human prostate cancer cells.
Topics: Adenocarcinoma; Animals; Calpain; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Screening Assays, Antitumor; Fibroblasts; Focal Adhesion Protein-Tyrosine Kinases; Humans; Ionomycin; Isoxazoles; Lysophospholipids; Male; Paxillin; Phosphorylation; Propionates; Prostatic Neoplasms; Proteolysis; Rats; Thapsigargin | 2012 |